Outcome of Complete Pulpotomy in Healthy and Type 2 Diabetic Patients in Permanent Teeth with Irreversible Pulpitis
1 other identifier
interventional
40
1 country
1
Brief Summary
Endodontic research on the effects of DM on pulp tissues is scarce. Diabetic human and animal histological research demonstrated a decreased reparatory response in the pulp, resulting in chronic pulp inflammation and reduced dentin bridge formation. To date, there is no human clinical trial examining the impact of diabetes mellitus on teeth with irreversible pulpitis. As a result of the paucity of data in the literature, there is a clinical dilemma whether to recommend vital pulp therapy techniques or root canal treatment in diabetic patients with irreversible pulpitis. To the best of our knowledge, no prospective study has evaluated the outcome of complete pulpotomy in T2DM patients and healthy controls with irreversible pulpitis. The aim of this preliminary study is to compare and evaluate the success rates of pulpotomy in healthy and type 2 diabetes mellitus patients in mature permanent teeth presenting with clinical symptoms of irreversible pulpitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedSeptember 19, 2024
November 1, 2023
1 year
December 6, 2023
September 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment outcome
Outcome of complete pulpotomy in healthy and diabetic patients through clinical and radiographic findings.
6 and 12 month follow-up.
Secondary Outcomes (1)
1) Effect of treatment on glycated haemoglobin levels in diabetic patients
3 months post-treatment
Study Arms (2)
diabetic group
EXPERIMENTALcomplete pulpotomy will be performed in teeth with irreversible pulpitis in diabetic patients.
Healthy group
ACTIVE COMPARATORcomplete pulpotomy will be performed in teeth with irreversible pulpitis in systemically healthy patients.
Interventions
Eligibility Criteria
You may qualify if:
- Type 2 diabetes mellitus with HbA1c \> 6.5% with no other co-morbidities.
- Age and gender matched healthy patients
- Age between 18 - 70 years.
- Mature permanent teeth with clinical and radiographic signs and symptoms indicative of irreversible pulpitis (PAI score ≤2)
- Tooth showing positive response to pulp sensibility testing.
You may not qualify if:
- Patients with immunocompromised diseases or systematic diseases (other than diabetes mellitus)
- Smokers, pregnant and lactating women
- Teeth with immature roots or retained deciduous tooth.
- Bleeding could not be controlled in ≥8 minutes.
- Tooth with signs and symptoms of apical periodontitis.
- Tooth with probing depth more than 4mm.
- Positive history of antibiotic use in the past 1 month or requiring antibiotic prophylaxis and/or analgesic usage in past 3 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr.keerthana
Rohtak, Haryana, 124001, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dr.keerthana G, MDS
PGIDS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The investigator and the outcome assessor will be blinded with the participants preoperative characteristics and allocation group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2023
First Posted
September 19, 2024
Study Start
August 1, 2023
Primary Completion
July 31, 2024
Study Completion
August 1, 2024
Last Updated
September 19, 2024
Record last verified: 2023-11